Search

Search Constraints

You searched for: Author/Creator Voss, M.

Search Results

1. 1165PImmune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas. (18th September 2017)

2. 354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer. (September 2015)

3. Gain-of-Function SAMD9L Mutations Cause a Syndrome of Cytopenia, Immunodeficiency, Myelodysplastic Syndrome and Neurological Symptoms. (April 2017)

4. Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC). (December 2016)